Related Experiment Video
Updated: Mar 7, 2026

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
Pharmacists' Advice about Driving for Diabetic Patients
1Ebisu Pharmacy.
Abstract:
In November 2013, the Japanese Ministry of Health, Labour and Welfare issued a directive that required the revision of the package inserts of 13 substances whose consumption carries risks associated with driving and the operation of machinery due to their side effects, such as dizziness. Medical personnel are required to remind patients taking these drugs about the risks, but the abovementioned directive did not apply to any antidiabetic drugs at that point. In January 2014, it was decided that patients should "pay attention while driving and at the workplace" when taking any antidiabetic drugs. This point is mentioned in the "important precautions" section of the drugs' package inserts. Since the revised Road Traffic Law was enacted in June 2014, the penalty for car accidents caused by a lack of awareness of hypoglycemia has increased. It has therefore become essential for medical personnel to instruct diabetic patients how to avoid falling unconscious due to hypoglycemia during driving. Patients taking antidiabetic drugs that are categorized as high-risk drugs are required to take an extra set of precautions and these are important for preventing severe hypoglycemia as well as reducing patients' cardiovascular risk. For more than 20 years, my pharmacy has been giving annual intensive counseling on hypoglycemia to diabetic patients. This counseling includes reminding patients about preventative measures, the risks associated with driving, and the need to keep a source of sugar in their cars. Only about 10% of diabetic patients keep a source of sugar in their cars.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hypoglycemia and Glucagon
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

